Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Nicholas Bown.

Newcastle AuthorsTitleYearFull text
Dr Carmela Ciardullo
Dr Jonathan Wallis
Dr Helen Marr
Dr Nicholas Bown
Dr Elaine Willmore
et al.
Splicing Modulation Results in Aberrant Isoforms and Protein Products of p53 Pathway Genes and the Sensitization of B Cells to Non-Genotoxic MDM2 Inhibition2023
Dr Timothy Barrow
Dr Sirintra Nakjang
Kateryna Bilotkach
Dr Laura Woodhouse
Gesa Junge
et al.
Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia2021
Dr Nicholas Bown
Professor Deborah Tweddle
Frequency and Prognostic Impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) High Risk Neuroblastoma trial (HRNBL-1)2021
Dr Nicholas Bown
Professor John Lunec
Professor Deborah Tweddle
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group2020
Swathi Merugu
Dr Lindi Chen
Elizabeth Gavens
Hany Gabra
Dr Al Gabriel
et al.
Detection of circulating and disseminated neuroblastoma cells using the Imagestream Imaging Flow Cytometer for use as predictive and pharmacodynamic biomarkers2020
Lucy Gentles
Liz Matheson
Dr Nicholas Bown
Alice Bradbury
Maryam Zanjirband Zanjirband
et al.
Characterization and drug sensitivity of a novel human overian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor2018
Dr Stephen Crosier
Dr Debbie Hicks
Dr Ed Schwalbe
Dr Daniel Williamson
Sarah Nicholson
et al.
Centralised Molecular Pathology for Rare Tumours: A National Feasibility Study of Real-Time Medulloblastoma Diagnostics2016
Richard Feltbower
Dr Richard McNally
Dr Nicholas Bown
Epidemiology of Ewing sarcoma in the north of England, 1990-20112016
Professor Steven Clifford
Dr Stephen Crosier
Dr Debbie Hicks
Stewart Nicholson
Dr Nicholas Bown
et al.
Establishment of national real-time central pathology review (CPR) and molecular diagnostics for medulloblastoma (MB)2016
Nermine Basta
Dr Gail Halliday
Richard Feltbower
Dr Nicholas Bown
Professor Andrew Pearson
et al.
Factors associated with recurrence and survival length following relapse in patients with neuroblastoma2016
Dr Lindi Chen
Angharad Humphreys
Dr Lisa Turnbull
Dr Nicholas Bown
Professor Deborah Tweddle
et al.
Identification of different ALK mutations in a pair of neuroblastoma cell lines established at diagnosis and relapse2016
Angharad Humphreys
Dr Al Gabriel
Dr Nicholas Bown
Dr Lindi Chen
Dr David Jamieson
et al.
Imaging flow-cytometer based detection of ALK and MDM2 amplification in neuroblastoma cell lines2016
Dr Nicholas Bown
Gavin Cuthbert
Dr David Bourn
Incidence and outcomes for adults diagnosed with acute myeloid leukemia in the north of England: a real world study2016
Dr Nicholas Bown
Gavin Cuthbert
Dr David Bourn
The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia - Response to Rashidi et al2016
Dr Timothy Barrow
Dr Laura Woodhouse
Gesa Junge
Dr Susan Tudhope
Dr Jonathan Wallis
et al.
The Role of HOXA4 in Chronic Lymphocytic Leukaemia Progression and Response to Therapy2016
Dr Sarra Ryan
Elizabeth Matheson
Dr Paul Sinclair
Dr Matthew Bashton
Claire Schwab
et al.
The role of the RAS pathway in iAMP21-ALL2016
Dr Mark Wade
Dr Nicola Sunter
Dr Sarah Fordham
Anna Long
Dino Mašić
et al.
c-MYC is a radiosensitive locus in human breast cells2015
Dr Simon Bomken
Dr Nicholas Bown
Dr Peter Carey
Dr Katrina Wood
Dr Kevin Windebank
et al.
Cutaneous B-Lymphoblastic Lymphoma With IL3/IgH Translocation Presenting With Hypereosinophilia and Acute Endocarditis2015
Dr Swethajit Biswas
Dr Nicholas Bown
Exome sequencing of an adult pituitary atypical teratoid rhabdoid tumor2015
Dr Nicholas Bown
Professor John Lunec
Professor Deborah Tweddle
Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification2015
Dr Nicholas Bown
Gavin Cuthbert
Dr Gail Jones
A United Kingdom Population-Based Study of Survival in Patients Aged 19 to 60 with Acute Myeloid Leukaemia in the Era of Molecular Genetics2014
Dr Nicholas Bown
Dr Sujith Samarasinghe
Professor Simon Bailey
Professor Roderick Skinner
FLT3 internal tandem duplication and NPM1 mutations in paediatric AML: a single centre experience2014
Dr Swethajit Biswas
Dr Nicholas Bown
Philip Kane
Whole-exome sequencing of an adult pituitary atypical teratoid rhabdoid tumor (AT/RT) - A not so simple genome as pediatric AT/RT2014
Professor Steven Clifford
Dr Stephen Crosier
Sarah Nicholson
Dr Nicholas Bown
A national feasibility study of real-time central pathology review (CPR) and molecular diagnostics for medulloblastoma2013
Dr Stephen Crosier
Sarah Nicholson
Dr Nicholas Bown
Professor Steven Clifford
A National Feasibility Study of Real-Time Central Pathology Review and Molecular Diagnostics for Medulloblastoma2012
Nermine Basta
Dr Gail Halliday
Richard Feltbower
Dr Nicholas Bown
Professor Andrew Pearson
et al.
Factors associated with recurrence and length of survival following relapse in patients with neuroblastoma: a pilot study2012
Dr Sarra Ryan
Dr Vikki Rand
Claire Schwab
Heather Morrison
Elizabeth Matheson
et al.
Ras Signalling Pathway and Novel Target Genes Related to Down Syndrome Contribute to the Development of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in iAMP21 Patients2011
Dr Elizabeth Jones
Dr Fiona Douglas
Dr Nicholas Bown
Wilms Tumor Incidence in Children With 2q Terminal Deletions: A Cohort Study2011
Dr Nicholas Bown
Dr Seamus O'Neill
17q gain in neuroblastoma predicts adverse clinical outcome2001
Gavin Cuthbert
Dr Nicholas Bown
Mike Cole
Comparison of three BCR/ABL FISH probe systems for quantitative interphase analysis2001
Dr Nicholas Bown
Dr Michael Reid
Dr Peter Hamilton
Professor Graham Jackson
Dr Penelope Taylor
et al.
Erythroleukaemia in the north of England: a population based study2001
Dr Maria Lastowska
Dr Nicholas Bown
Professor Andrew Pearson
Multicentre analysis of patterns of DNA gains and losses in 204 neuroblastoma tumors: How many genetic subgroups are there?2001
Dr Nicholas Bown
Neuroblastoma tumour genetics: Clinical and biological aspects2001
Gavin Cuthbert
Dr Nicholas Bown
Amplification of the MLL gene in leukaemia: a UK Cancer Cytogenetics Group study1999
Gavin Cuthbert
Dr Nicholas Bown
Jumping translocation at 11q23 with MLL gene rearrangement and interstitial telomeric sequences1999
Gavin Cuthbert
Dr Nicholas Bown
Sensitivity of FISH in detection of MLL gene rearrangements1999